Feedback / Questions
zabilugene almadenorepvec (VCN-01) - Theriva Bio
https://www.globenewswire.com/news-release/2026/02/03/3231020/0/en/Theriva-Biologics-Announces-Upcoming-Presentation-of-Data-from-VCN-01-Retinoblastoma-Phase-1-Clinical-Trial-at-APAO-2026.html
Feb 3, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next